July 22, 2015
A Mylan NV shareholder sued the pharmaceutical company, its CEO and a board member in Pennsylvania federal court Tuesday, claiming the leaders improperly concealed the circumstances of a tax inversion and orchestrated an unlawful call option to kill a potential acquisition by Teva Pharmaceutical Industries Ltd.